Authors
Latest:
Modernizing GxP Compliance in Life Sciences: The Role of Digital Tools and Validation ExpertiseIn an era of increasing regulatory complexity, life sciences organizations are modernizing GxP compliance through digital tools like eQMS, cloud platforms, and automated validation, while expert validation services remain essential for aligning these technologies with real-world workflows and inspection readiness.
Latest:
Fostering Patient Engagement with PortalsSix engagement tips for companies to consider to improve patient use of portals
Latest:
How pharma and HCPs can support backlogged pandemic patientsFocusing on key groups will drive the greatest impact in health outcomes
Latest:
Adding Might to ‘Specialty Lite’Not quite specialty, not quite retail: Cost-effective access and support strategies for a growing, yet underserved, treatment market
Latest:
Why Reliable Pharma Shipping Outweighs CostAlthough companies are faced with constraints, regulations, and challenges in this space, the positives supersede the negatives.
Latest:
From Toggling Tediously Between Systems to Achieving Whole-Person CareThe rationale behind transforming case management in healthcare.
Latest:
Navigating Digital Transformation Fatigue: The Strategy for Success in Regulated IndustriesDigital transformation initiatives are often complex endeavors that can significantly impact the way organizations operate.
Latest:
The True Reliability of Real-World DataOutlining five questions that should be considered when assessing if RWD is “fit for purpose” in pharma research—and ultimately clinical and pharmacy decision support
Latest:
Harnessing the Potential of Data to Deliver the Future of HealthcareFaster approvals, more accurate and timely medicines monitoring—all enabled by harmonized, consistent and reliable data—will drive improved patient outcomes.
Latest:
Changing the PAP ModelThe advantages and challenges associated with structuring a patient assistance program as a non-profit foundation.
Latest:
Developing Your Roadmap to Pharma 4.0Questions to ask before transitioning into new technologies. By Yvonne Duckworth and Cory Perelman.
Latest:
Beyond the Brand Team: Why Every Employee Needs to Be Part of the JourneyEngaging the full workforce—from HR to R&D—can elevate launch outcomes, build trust, and create long-term brand ambassadors.
Latest:
Patient Centricity in the Pharma Supply ChainThe importance of industry, as it moves forward, in focusing on patient-centered care and prioritizing patient needs across the supply chain.
Latest:
Patient Services: A Marathon, Not A SprintRob Truckenmiller, CEO of PharmaCord, talks about the company’s role in patient services, trends he sees shaping patient access to healthcare in the U.S., and a recent patient-centric merger.
Latest:
The Evolving Value Assessment Landscape in the USHow current frameworks influence coverage decisions and pricing negotiations.
Latest:
What Makes Hub Programs Successful?Outlining the core functional skill sets of the most effective hub programs—all toward the goal of helping patients get on prescriptions as quickly as possible
Latest:
Measuring What MattersWays to reimagine pharma’s operating model and KPIs for commercial success in an AI-driven future.
Latest:
From Aisles to Access: How Grocery-Based Pharmacies are Evolving into Community Health HubsAmid the growing crisis of pharmacy deserts, these entities are tapping new avenues in care delivery, including the integration of clinical services, nutrition counseling, and real-time patient education.
Latest:
Maximizing HCP engagement as the definition of a sales ‘call’ expandsHow pharma’s retooling of its promotional efforts in the post-pandemic era impacts sizing and targeting, two crucial foundational pieces to successful commercialization
Latest:
After a Decade of Regulatory Transformation, What’s Next?Following a decade of solid groundwork to modernize regulatory information management in life sciences, leading companies have now shifted their focus to how they might exploit this new digital landscape
Latest:
FDA Delays Regeneron’s Odronextamab, Eylea HD Regulatory Decisions Over Catalent Site IssuesRegeneron has received a second complete response letter from the FDA for odronextamab and anticipates delays for Eylea HD due to inspection findings at a Catalent manufacturing site, despite continued strong revenue growth and pipeline momentum.
Latest:
Succeeding with Fit-for-Purpose AIHow artificial intelligence is improving the patient experience
Latest:
Drug Shortages: A Chronic Problem, but New Opportunities Present ThemselvesWhile this concern is causing ripples in the global supply chain, technological and regulatory advances can help address the issue
Latest:
Developing a Successful Data & Analytics Strategy: Four Common QuestionsA comprehensive data and analytics strategy is now table stakes for pharmaceutical and life science organizations, writes Simon Andrews
Latest:
The Impact of 340B on Commercial ContractsDuplicate rebates have resulted in revenue leakage for manufacturers.
Latest:
Congress Leaves Town with Major Drug-Related Bills on HoldPandemic preparedness and curbing PBMs among the pending legislation that will have to wait until after summer recess.
Latest:
What’s Next for Biopharma Under the Inflation Reduction ActAs we approach the one-year anniversary of the IRA being signed into law, questions remain about how the new law will reverberate changes across the biopharma industry.
Latest:
Bolstering Health Technology Assessment With the Help of AIWays to address limitations while also enhancing the decision-making process.
Latest:
Positioning the Patient in Drug TrialsThe clinical research industry must integrate feedback from patients and sites to eliminate unnecessary burden and accelerate enrollment in clinical trials
Latest:
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
